TrialMedicine2020

A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome).

Lijun Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.